Psychiatry & Behavioral Sciences

Psychiatry & Behavioral Sciences

The Department of Psychiatry and Behavioral Sciences strives to promote new discoveries and understand well-being and mental health across the lifespan using insights from clinical and fundamental neuroscience.  Clinicians engage in multidisciplinary, interdisciplinary, and transdisciplinary efforts that are uniquely possible at Stanford University.


Psychiatry & Behavioral Sciences News

  • Ioannidis on antidepressant efficacy

    In a highly comprehensive meta-analysis of more than 500 clinical trials, researchers from around the world have drawn conclusions about the efficacy of 21 different antidepressants.


  • Autism research funds awarded

    Three Stanford psychiatry researchers have been awarded $2.5 million to investigate patients with autism who also have enlarged brains, a condition known as megalencephaly.


  • New guidelines for PANS/PANDAS

    Stanford clinicians helped develop the first clinical guidelines for treating pediatric acute-onset neuropsychiatric syndrome, a psychiatric problem linked to brain inflammation.


  • Initiative for brain health launched

    Brainstorm’s first event featured a competition between researchers who designed virtual-reality products for diagnosing and treating mental illness.


  • DACA and children’s mental health

    Children with mothers eligible for the Deferred Action for Childhood Arrivals program suffer from lower rates of anxiety and adjustment disorders than those with mothers who lack DACA eligibility.



Join the Mailing List

New activities are added regularly. Join our mailing list to receive notifications about activities of interest to you.

Related Clinical Trials

Showing 1 - 20 of 32 trials